NCT07931664: Evaluating Photodynamic Therapy Used to Treat Cutaneous Squamous Cell Carcinoma in Situ (isSCC) on the Face, Upper Extremities & Trunk.
- State
- Under way
- Phase
- Phase 2
- People
- 30 planned
- Started
- 25 Nov 2025
- Primary completion
- Nov 2026
- Arms
- Facial isSCC Photodynamic Therapy (Blue light dose 10 J/cm2), Trunk and/or upper extremities isSCC Photodynamic Therapy (Blue light dose 10 J/cm2)
- Results
- None posted
- 25 Nov 2025: Trial started
- 12 Nov 2026: Trial registered